Enterprise applications

Prepare for the consequences of medical change.

NextConsensus estimates the probability of defined authority transitions at rungs 5–7. Evidence, access, portfolio, competitive-intelligence, and claim teams can privately map those forecasts to the consequences that matter to them at rungs 8–12.

Review the Forecasting Standard Programs

Defined forecast targets (rungs 5–7)

Start with the public action, then map its consequences.

Each forecast names the authority, action, deadline, and upstream states observed. Enterprise teams decide how a resolved or high-probability transition affects evidence plans, access strategy, portfolio assumptions, competitive interpretation, or approved claims.

Rung 5

Guideline recommendation shift

Event

A major clinical society updates standard-of-care guidelines, modifying recommended therapies, patient thresholds, or clinical pathways.

Proposition format

Will the ACC/AHA update heart failure guidelines to recommend [therapy] as Class I by [date]?

Upstream states observed

Rungs 1–4: peer-reviewed trial readouts, replication studies, key opinion leader (KOL) consensus, and real-world confirmation.

Who uses this forecast

Medical AffairsClinical CommunicationsScientific Relations

What the forecast enables

Can help medical communication teams prepare internal evidence and claim reviews for a guideline transition without treating the forecast as the decision.

Rung 6

Regulatory label boundary shift

Event

A regulatory body modifies a drug or device label, adjusting contraindications, patient subpopulation criteria, or warnings.

Proposition format

Will the FDA restrict the approved indication for [drug] to exclude patients with [condition] by [date]?

Upstream states observed

Rungs 1–4: post-market registry safety signals, advisory committee recommendations, and clinical trial subgroup readouts.

Who uses this forecast

Regulatory AffairsMLR ComplianceLegal Counsel

What the forecast enables

Can help MLR teams decide when a privately governed review of affected materials is worth initiating before a registered regulatory deadline.

Rung 7

Payer coverage restrictions & LCDs

Event

Payers or health authorities restrict coverage criteria, enforcing step-therapy or narrowing reimbursement boundaries.

Proposition format

Will CMS issue a restrictive National Coverage Determination (NCD) for [therapy class] by [date]?

Upstream states observed

Rungs 1–4: cost-effectiveness trial publications, HEOR analyses, and societal guideline updates.

Who uses this forecast

Market AccessHEORPayer Relations

What the forecast enables

Can help market access teams map a payer transition to internal evidence plans, value materials, and scenario assumptions under their own decision controls.

Getting started

Start with the transition you care about most.

Name the authority, public action, and deadline. We will determine whether the proposition is measurable.

Review the Forecasting Standard Programs